MDT

98.74

-1.06%↓

A

145.66

-1.47%↓

VEEV

241.02

+0.99%↑

HQY

98.46

+0.84%↑

PHR.US

16.88

-3.21%↓

MDT

98.74

-1.06%↓

A

145.66

-1.47%↓

VEEV

241.02

+0.99%↑

HQY

98.46

+0.84%↑

PHR.US

16.88

-3.21%↓

MDT

98.74

-1.06%↓

A

145.66

-1.47%↓

VEEV

241.02

+0.99%↑

HQY

98.46

+0.84%↑

PHR.US

16.88

-3.21%↓

MDT

98.74

-1.06%↓

A

145.66

-1.47%↓

VEEV

241.02

+0.99%↑

HQY

98.46

+0.84%↑

PHR.US

16.88

-3.21%↓

MDT

98.74

-1.06%↓

A

145.66

-1.47%↓

VEEV

241.02

+0.99%↑

HQY

98.46

+0.84%↑

PHR.US

16.88

-3.21%↓

Search

CareDx Inc

Cerrado

SectorSalud

17.25 -8.29

Resumen

Variación precio

24h

Actual

Mínimo

17.11

Máximo

18.81

Métricas clave

By Trading Economics

Ingresos

10M

1.7M

Ventas

13M

100M

P/B

Media del Sector

15.477

87.826

Margen de beneficio

1.674

Empleados

644

EBITDA

11M

6.8M

Recomendaciones

By TipRanks

Recomendaciones

Neutral

Estimación a 12 meses

+16.4% upside

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

268M

1.1B

Apertura anterior

25.54

Cierre anterior

17.25

Noticias sobre sentimiento de mercado

By Acuity

44%

56%

161 / 372 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Neutral Evidence

CareDx Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

7 ene 2026, 23:11 UTC

Ganancias

Samsung Electronics Expects Record Fourth-Quarter Profit Beat

7 ene 2026, 22:55 UTC

Principales Movimientos del Mercado

Defense Stocks Rebound After Trump Says He Wants $1.5 Trillion Military Budget in 2027

7 ene 2026, 21:39 UTC

Principales Movimientos del Mercado

Raytheon Down Following Trump Post Criticizing Company

7 ene 2026, 20:13 UTC

Principales Movimientos del Mercado

AbbVie, Revolution Medicines Stocks Gain on Report of Possible Acquisition

7 ene 2026, 20:03 UTC

Principales Movimientos del Mercado

Defense Contractor Shares Fall on Trump's Push to Ban Industry Dividends, Buybacks, Limit Executive Pay

7 ene 2026, 23:46 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

7 ene 2026, 23:46 UTC

Charlas de Mercado

Nikkei May Decline as China-Japan Tensions Linger -- Market Talk

7 ene 2026, 23:42 UTC

Adquisiciones, fusiones, absorciones

Warner Discovery Rejects Paramount's Amended Hostile Bid -- 5th Update

7 ene 2026, 23:34 UTC

Charlas de Mercado

Gold Edges Higher Amid Lingering Geopolitical Risks -- Market Talk

7 ene 2026, 23:29 UTC

Adquisiciones, fusiones, absorciones

Constellation Closes Deal for Calpine, Creating Biggest Electricity Generator -- Barrons.com

7 ene 2026, 22:48 UTC

Charlas de Mercado

Infratil's Discount to Net Asset Value Too Good to Ignore -- Market Talk

7 ene 2026, 22:46 UTC

Ganancias

Samsung Electronics Estimates 2025 Rev KRW332.770T Vs KRW300.870T >005930.SE

7 ene 2026, 22:45 UTC

Ganancias

Samsung Electronics Estimates 2025 Oper Pft KRW43.530T Vs KRW32.730T >005930.SE

7 ene 2026, 22:43 UTC

Adquisiciones, fusiones, absorciones

Revolution Medicines Draws Takeover Interest -- 2nd Update

7 ene 2026, 22:42 UTC

Ganancias

Samsung Electronics 4Q Oper Pft Estimate Beat FactSet-Compiled Consensus Forecast

7 ene 2026, 22:41 UTC

Ganancias

Samsung Electronics Sees 4Q Oper Pft KRW20.000T Vs KRW6.490T >005930.SE

7 ene 2026, 22:41 UTC

Ganancias

Samsung Electronics Sees 4Q Rev KRW93.000T Vs KRW75.790T >005930.SE

7 ene 2026, 22:40 UTC

Principales Movimientos del Mercado

Defense Stocks Rebound After Trump Says He Wants $1.5T Military Budget in 2027

7 ene 2026, 22:31 UTC

Charlas de Mercado

Macro Tailwinds Strengthen for Chalice Mining -- Market Talk

7 ene 2026, 22:22 UTC

Charlas de Mercado

Northern Star's Run of Disruptions Increasingly a Concern -- Market Talk

7 ene 2026, 22:01 UTC

Charlas de Mercado

Valuations of New Zealand Property Stocks Supportive -- Market Talk

7 ene 2026, 21:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

7 ene 2026, 21:46 UTC

Charlas de Mercado

Northern Star's Revised Guidance Looks Achievable -- Market Talk

7 ene 2026, 21:22 UTC

Adquisiciones, fusiones, absorciones

Eli Lilly to Buy Ventyx Biosciences for $14 a Share >LLY VTYX

7 ene 2026, 21:18 UTC

Adquisiciones, fusiones, absorciones

Lilly To Acquire Ventyx Biosciences To Advance Oral Therapies Targeting Inflammatory-mediated Diseases >LLY VTYX

7 ene 2026, 21:05 UTC

Adquisiciones, fusiones, absorciones

Warner Discovery Rejects Paramount's Amended Hostile Bid -- 4th Update

7 ene 2026, 20:29 UTC

Adquisiciones, fusiones, absorciones

AbbVie Near Deal for Revolution Medicines -- Update

7 ene 2026, 20:27 UTC

Charlas de Mercado

U.S. Natural Gas Futures Snap Losing Streak -- Market Talk

7 ene 2026, 19:58 UTC

Charlas de Mercado

Oil Falls As U.S. to Receive Sanctioned Venezuelan Crude -- Market Talk

7 ene 2026, 19:48 UTC

Principales Movimientos del Mercado

Defense Contractor Shares Fall on Trump's Push to Ban Industry Dividends, Buybacks, Limit Exec Pay

Comparación entre iguales

Cambio de precio

CareDx Inc Esperado

Precio Objetivo

By TipRanks

16.4% repunte

Estimación a 12 meses

Media 22 USD  16.4%

Máximo 26 USD

Mínimo 18 USD

De acuerdo con 4 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para CareDx Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Neutral

4 ratings

0

Comprar

4

Mantener

0

Vender

Puntuación técnica

By Trading Central

14.77 / 18.49Soporte y Resistencia

Corto Plazo

Neutral Evidence

Medio plazo

Strong Bearish Evidence

Largo Plazo

Weak Bearish Evidence

Sentimiento

By Acuity

161 / 372 Clasificación en Salud

Noticias sobre sentimiento de mercado

Coyuntura alcista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por encima de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de CareDx Inc

CareDx, Inc. engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally. It also provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The company offers Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; QTYPE that enables precision in HLA typing; and Ottr, a transplant patient management software. In addition, it provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; Allocell, a surveillance solution that monitors the level of engraftment and persistence of allogeneic cells for patients who have received cell therapy transplants; and XynQAPI cloud-based transplant quality management software, as well as AlloCare, a mobile app that offers a patient-centric resource for transplant recipients. The company offers its products directly to customers, as well as through third-party distributors and sub-distributors. It has a license agreement with Illumina, Inc. for the distribution, development, and commercialization of NGS products and technologies; and Cibiltech SAS to commercialize iBox, a software for the predictive analysis of post-transplantation kidney allograft loss. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. The company was incorporated in 1998 and is headquartered in South San Francisco, California.
help-icon Live chat